{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T18:41:28Z","timestamp":1771267288596,"version":"3.50.1"},"reference-count":23,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2020,1,5]]},"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:p>A previously healthy 11-month-old infant presented to the emergency department in status epilepticus. There was no clear trigger of her seizure activity which resolved with benzodiazepines and fosphenytoin. On further review, her parents disclosed that she had been prescribed topical 4% lidocaine cream for a groin rash and was ultimately diagnosed with lidocaine toxicity in the emergency department. She was monitored in the intensive care unit without cardiovascular abnormalities or recurrence of seizure activity. Emergency medicine providers must maintain a broader differential of status epileptics and be able to recognise and manage potential complications from systemic lidocaine toxicity.<\/jats:p>","DOI":"10.1136\/bcr-2019-233119","type":"journal-article","created":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T04:15:14Z","timestamp":1578888914000},"page":"e233119","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Infant with status epilepticus secondary to systemic lidocaine toxicity from topical application"],"prefix":"10.1136","volume":"13","author":[{"given":"Erica","family":"Walters","sequence":"first","affiliation":[{"name":"Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Wurster Ovalle","sequence":"additional","affiliation":[{"name":"Emergency Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Yin","sequence":"additional","affiliation":[{"name":"Drug and Poison Information Center, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA"},{"name":"Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Dribin","sequence":"additional","affiliation":[{"name":"Emergency Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA"},{"name":"Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,1,12]]},"reference":[{"key":"2025082711494853000_13.1.e233119.1","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/S0140-6736(19)30722-6","article-title":"Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial","volume":"393","author":"Dalziel","year":"2019","journal-title":"Lancet"},{"key":"2025082711494853000_13.1.e233119.2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.seizure.2018.05.011","article-title":"New-onset seizure presenting as status epilepticus: etiology and clinical characteristics in a cohort of 236 children","volume":"63","author":"Kravljanac","year":"2018","journal-title":"Seizure"},{"key":"2025082711494853000_13.1.e233119.3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2006.00319.x"},{"key":"2025082711494853000_13.1.e233119.4","doi-asserted-by":"publisher","DOI":"10.1097\/PEC.0b013e3182854790"},{"key":"2025082711494853000_13.1.e233119.5","doi-asserted-by":"publisher","DOI":"10.1097\/00006565-200008000-00009"},{"key":"2025082711494853000_13.1.e233119.6","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jemermed.2016.05.034","article-title":"Lidocaine toxicity during attempted epistaxis cautery","volume":"51","author":"Nicholas","year":"2016","journal-title":"J Emerg Med"},{"key":"2025082711494853000_13.1.e233119.7","doi-asserted-by":"publisher","DOI":"10.1177\/0883073813483570"},{"key":"2025082711494853000_13.1.e233119.8","unstructured":"Wolters Kluwer Clinical Drug Information, Inc . Lexicomp Online: Pediatric & Neonatal Lexi-Drugs Online [database. Hudson (OH): Wolters Kluwer Clinical Drug Information, Inc, 2019. https:\/\/www.uptodate.com\/contents\/lidocaine-topical-pediatric-drug-information"},{"key":"2025082711494853000_13.1.e233119.9","unstructured":"Butterworth JF , Mackey DC , Wasnick JD . Chapter 16. Local Anesthetics. In: Morgan & Mikhail\u2019s Clinical Anesthesiology. 5th edn. New York, NY: The McGraw-Hill Companies, 2013. http:\/\/accessmedicine.mhmedical.com\/content.aspx?aid=57232174"},{"key":"2025082711494853000_13.1.e233119.10","doi-asserted-by":"publisher","DOI":"10.2165\/00128072-200204100-00003"},{"key":"2025082711494853000_13.1.e233119.11","doi-asserted-by":"publisher","DOI":"10.2344\/0003-3006(2006)53[98:EOLAP]2.0.CO;2"},{"key":"2025082711494853000_13.1.e233119.12","doi-asserted-by":"publisher","DOI":"10.1177\/000992288302200306"},{"key":"2025082711494853000_13.1.e233119.13","doi-asserted-by":"crossref","first-page":"450","DOI":"10.4103\/0970-9185.169049","article-title":"Topical anesthesia","volume":"31","author":"Kumar","year":"2015","journal-title":"J Anaesthesiol Clin Pharmacol"},{"key":"2025082711494853000_13.1.e233119.14","doi-asserted-by":"publisher","DOI":"10.1097\/AAP.0000000000000726"},{"key":"2025082711494853000_13.1.e233119.15","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.113.051714"},{"key":"2025082711494853000_13.1.e233119.16","doi-asserted-by":"publisher","DOI":"10.1213\/ane.0b013e318187c4b1"},{"key":"2025082711494853000_13.1.e233119.17","doi-asserted-by":"publisher","DOI":"10.1177\/106002809402800515"},{"key":"2025082711494853000_13.1.e233119.18","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e3181afde0a"},{"key":"2025082711494853000_13.1.e233119.19","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s13181-016-0550-z","article-title":"ACMT position statement: guidance for the use of intravenous lipid emulsion.","volume":"13","year":"2017","journal-title":"J Med Toxicol"},{"key":"2025082711494853000_13.1.e233119.20","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0b013e318284123e"},{"key":"2025082711494853000_13.1.e233119.21","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e318287f874"},{"key":"2025082711494853000_13.1.e233119.22","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e31825ad8de"},{"key":"2025082711494853000_13.1.e233119.23","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3109\/15563650.2015.1121270","article-title":"Systematic review of the effect of intravenous lipid emulsion therapy for local anesthetic toxicity","volume":"54","author":"Hoegberg","year":"2016","journal-title":"Clin Toxicol"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2019-233119","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T18:49:56Z","timestamp":1756320596000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2019-233119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1,12]]},"published-print":{"date-parts":[[2020,1]]}},"alternative-id":["10.1136\/bcr-2019-233119"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2019-233119","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1]]}}}